Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

Abstract:

BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients with AGC. METHODS:Patients with previously untreated AGC received intravenous oxaliplatin 130 mg/m(2) over 2 h on day 1 plus oral capecitabine 1,000 mg/m(2) twice daily on days 1-14, every 3 weeks. Treatment was continued for 8 cycles or until disease progression or intolerable toxicity. RESULTS:Fifty patients were enrolled. In total, 210 cycles of XELOX were delivered. The OVERALL response rate was 42% (95% CI 28.6-56.7), with 2 complete and 19 partial responses. At 15.2 months of median follow-up, median time to progression and overall survival were 5.8 (95% CI 3.4-8.2) and 11.1 (95% CI 5.6-16.5) months, respectively. The most common hematological adverse event was neutropenia (56% of patients); grade 3-4 neutropenia was observed in 6 patients, with neutropenic fever in only 2 patients. The most common non-hematological toxicities were vomiting (34%), hand-foot syndrome (26%), diarrhea (24%) and neurosensory toxicity (22%). There were no treatment-related deaths. CONCLUSIONS:XELOX is active for the first-line treatment of AGC with a manageable tolerability profile.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

doi

10.1159/000305256

subject

Has Abstract

pub_date

2010-01-01 00:00:00

pages

94-100

issue

2

eissn

0009-3157

issn

1421-9794

pii

000305256

journal_volume

56

pub_type

杂志文章
  • Bactericidal effect of levofloxacin on strains with equal susceptibility in an in vitro urinary bladder model.

    abstract::The in vitro bactericidal effects of therapeutic concentrations of levofloxacin (LVFX) on clinical isolates of Pseudomonas aeruginosa and Enterococcus faecalis were assessed. Starting from 10(7) CFU/ml, the bacterial count was determined serially during the exposure to LVFX present at concentrations automatically simu...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007133

    authors: Takahashi S,Sano M,Nishimura M,Matsukawa M,Mikami M,Hirose T,Tsukamoto T

    更新日期:1998-09-01 00:00:00

  • The clinical use of aztreonam.

    abstract::Aztreonam is the first monobactam antibiotic to be used clinically. It is highly resistant to beta-lactamases, and although its activity spectrum is similar to that of the aminoglycoside antibiotics, it has no effect on gram-positive bacteria. The current study was undertaken to determine the efficacy of aztreonam in ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238720

    authors: Schönwald S,Schoss-Vidensek Z,Car V,Krznar B

    更新日期:1989-01-01 00:00:00

  • Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages.

    abstract::The effect of acyclovir (ACV) treatment on selected functions of human blood-derived macrophages was examined. ACV was not cytotoxic when applied in a wide range of concentrations. Only minor effects on macrophage functions were observed when cells were treated with therapeutic concentrations of ACV:phagocytosis and t...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239126

    authors: Stenseth AM,Rollag H,Degré M

    更新日期:1993-05-01 00:00:00

  • The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer.

    abstract:OBJECTIVE:The aim of this study was to assess the value of tumor markers in monitoring chemotherapy response and predicting prognosis in patients with advanced non-small cell lung cancer (NSCLC). METHODS:We studied carcinoembryonic antigen (CEA), CYFRA21-1 and neuron-specific enolase (NSE) of 111 untreated patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000317580

    authors: Jin B,Huang AM,Zhong RB,Han BH

    更新日期:2010-01-01 00:00:00

  • Therapeutic activity of pretazettine, standard drugs, and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice.

    abstract::Therapeutic effectiveness of pretazettine (PTZ) has been demonstrated in the intraperitoneally (i.p.) implanted Lewis lung carcinoma (LLC) in both syngeneic and allogeneic mice. The i.p. implanted LLC has been found to be sensitive to most standard drugs tested such as cyclophosphamide (CY), actinomycin D, 5-fluoroura...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238212

    authors: Furusawa E,Furusawa E,Sokugawa L

    更新日期:1983-01-01 00:00:00

  • Biliary excretion of cefaclor. Experimental and clinical study.

    abstract::Biliary excretion of cefaclor, a new orally active cephalosporin, was studied in vitro using an isolated rabbit liver preparation perfused for 3 h (n = 5). Under these conditions, bile recovery amounted to 2.3% of the cefaclor dose added to the circulating blood (10 mg). In humans, after oral administration of a 1-gra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238075

    authors: Brogard JM,Pinget M,Comte F,Adloff M,Lavillaureix J

    更新日期:1982-01-01 00:00:00

  • 5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy.

    abstract:BACKGROUND/AIMS:There is no standard consensus on a strategy in the second-line setting for gemcitabine-refractory advanced pancreatic cancer. This study evaluated the activity and tolerability of oxaliplatin, irinotecan, 5-fluorouracil and leucovorin (FOLFIRINOX) as a second-line therapy in advanced pancreatic adenoca...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000356158

    authors: Lee MG,Lee SH,Lee SJ,Lee YS,Hwang JH,Ryu JK,Kim YT,Kim DU,Woo SM

    更新日期:2013-01-01 00:00:00

  • Comparative antibacterial activity of the penem ALP 201.

    abstract::The minimum inhibitory concentration (MIC) of the new penem ALP 201 was tested against 243 recent clinical isolates of which 95 were from the family Enterobacteriaceae, 50 were from the genus Streptococcus, 50 were Staphylococcus aureus and 48 were Staphylococcus epidermidis. An agar dilution technique was used to det...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238888

    authors: Bergan T,da Fonseca J

    更新日期:1991-01-01 00:00:00

  • Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.

    abstract::Cisplatin (cis-diamminedichloroplatinum(II), CDDP) is one of the most important chemotherapeutic agents; however, the mechanisms of resistance to this drug are still unknown. Recent reports have demonstrated that chemotherapy can induce apoptosis in some cancer cells, indicating that apoptosis may play a very importan...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007258

    authors: Mese H,Sasaki A,Alcalde RE,Nakayama S,Matsumura T

    更新日期:2000-01-01 00:00:00

  • Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.

    abstract::A total of 1,442 patients with symptoms of chronic prostatitis were examined over a 4-year period at the Outpatient Department for Urogenital Infections, University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia. The inclusion criteria for chronic prostatitis caused by Ureaplasma urealyticum wer...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000090234

    authors: Skerk V,Mareković I,Markovinović L,Begovac J,Skerk V,Barsić N,Majdak-Gluhinić V

    更新日期:2006-01-01 00:00:00

  • Penetration of clarithromycin into human saliva.

    abstract::The concentrations of clarithromycin after a single oral dose of 500 mg were determined in serum and saliva of ten healthy adult volunteers. After 2 h, the levels were 4.04 +/- 1.14 (SD) mg/l in serum and 2.72 +/- 0.87 mg/l in saliva. After 7 h these values were 1.98 +/- 0.65 and 1.21 +/- 0.34 mg/l, respectively, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239139

    authors: Wüst J,Hardegger U

    更新日期:1993-09-01 00:00:00

  • Derivation of meropenem dosage in patients receiving continuous veno-venous hemofiltration based on pharmacodynamic target attainment.

    abstract:BACKGROUND:Dosage recommendations for antibiotics in patients receiving continuous veno-venous hemofiltration (CVVH) should be based on pharmacodynamic requirements. For meropenem, this would be achieving appropriate time above the minimum inhibitory concentration (T > MIC). We employed Monte Carlo simulation to calcul...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000086598

    authors: Kuti JL,Nicolau DP

    更新日期:2005-07-01 00:00:00

  • Cefotaxime (HR-756) in urinary tract infections.

    abstract::A total of 30 hospitalized patients with upper and lower urinary tract infections were treated with cefotaxime (HR-756) by intramuscular or intravenous route. All patients had a monomicrobial infection, and the major part of bacterial isolates were gram-negative bacilli (83%) while gram-positive cocci accounted only f...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238061

    authors: Paradisi F,Cristiano P,Mirone V,D'Armiento V,Iovene MR

    更新日期:1982-01-01 00:00:00

  • Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin.

    abstract::Viscum album (VA) preparations consist of aqueous extracts of V. album, the European mistletoe. VA extracts contain mistletoe lectins, which are members of the ribosome-inactivating protein type II family. VA preparations have cytotoxic and immunomodulatory properties. Cytotoxicity induced by VA extracts may differ gr...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000074530

    authors: Duong Van Huyen JP,Delignat S,Kazatchkine MD,Kaveri SV

    更新日期:2003-12-01 00:00:00

  • The pharmacokinetics of new oral cephalosporins in children.

    abstract::Differences in the pharmacokinetic parameters of cephalosporins between children and adults may be predictable on the basis of the level of maturation of the physiologic processes involved in drug disposition. It appears that the most important of these factors (gastrointestinal, renal and hepatic function) are reason...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000239090

    authors: Edwards DJ,Stoeckel K

    更新日期:1992-01-01 00:00:00

  • Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.

    abstract::The in vitro activity of ceftazidime has been compared with those of cephalothin, cefuroxime, and netilmicin against a variety of gram-positive and gram-negative bacteria in order to register sensitivity patterns in the western part of Norway. An agar dilution method was used for minimal inhibitory concentration (MIC)...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238256

    authors: Digranes A,Dibb WL,Benonisen E

    更新日期:1984-01-01 00:00:00

  • Increased resistance of encapsulated Bacteroides fragilis to clindamycin.

    abstract::The antimicrobial susceptibility and in vitro growth curve of 4 nonencapsulated and 4 encapsulated isolates of Bacteroides fragilis were determined for clindamycin. The MIC of the nonencapsulated isolates was 1-2 dilutions less (0.062-0.25 microgram/ml) than the MIC for their encapsulated counterparts (0.25-0.5 microg...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239164

    authors: Brook I,Gillmore JD

    更新日期:1994-01-01 00:00:00

  • Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.

    abstract:BACKGROUND:This study was conducted to determine the antimicrobial susceptibility patterns among common pathogens in the intensive care unit (ICU) of a university hospital in Iran between 2006 and 2009. METHODS:The isolates cultured in appropriate media and antimicrobial susceptibility were determined by disk diffusio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000321032

    authors: Mohammadtaheri Z,Pourpaki M,Mohammadi F,Namdar R,Masjedi MR

    更新日期:2010-01-01 00:00:00

  • Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.

    abstract::In children undergoing anticancer chemotherapy, a granulocytopenic febrile episode is a life-threatening condition. Prompt initiation of empirical broad-spectrum antibiotics is essential to limit morbidity and mortality. To evaluate the cost-effectiveness of combination antibiotics consisting of a third generation cep...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239590

    authors: Pession A,Prete A,Paolucci G

    更新日期:1997-09-01 00:00:00

  • Nutrient-starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

    abstract::Pyrazinamide (PZA) is an unconventional frontline tuberculosis drug characterized by high in vivo sterilizing activity, but poor in vitro activity. The study on the mechanism of action of PZA has attracted significant attention because of the peculiarity of PZA and its ability to shorten the tuberculosis chemotherapy....

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000107723

    authors: Huang Q,Chen ZF,Li YY,Zhang Y,Ren Y,Fu Z,Xu SQ

    更新日期:2007-01-01 00:00:00

  • Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

    abstract::The pharmacokinetics of ceftriaxone (CRO) after subcutaneous and intravenous administration was studied in 10 healthy volunteers (5 males, 5 females, age 22-43 years, body weight 64.3 +/- 9.5 kg). Each of them received 2.0 g CRO i.v., and then 0.5 g i.v. and 0.5 g CRO s.c. in a randomized cross-over design. Subcutaneo...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238342

    authors: Borner K,Lode H,Hampel B,Pfeuffer M,Koeppe P

    更新日期:1985-01-01 00:00:00

  • Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruzi.

    abstract::Eight thiadiazine 1,1-dioxide derivatives were evaluated for antitrichomonal and antitrypanosomal activities. In vivo tests were performed on a murine model for trichomoniasis standardized in our laboratory. The capacity of compounds to clear visceral lesions in experimentally infected animals as well as their effects...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239040

    authors: Atienza J,Martínez Díaz RA,Gómez Barrio A,Escario JA,Herrero A,Ochoa C,Rodríguez J

    更新日期:1992-01-01 00:00:00

  • Dihydroergotamine Tartrate Induces Lung Cancer Cell Death through Apoptosis and Mitophagy.

    abstract:BACKGROUND:Mitochondria have emerged as a major target for anticancer therapy because of their critical role in cancer cell survival. Our preliminary works have suggested that dihydroergotamine tartrate (DHE), an antimigraine agent, may have effects on mitochondria. METHODS:We examined the effect of DHE on the surviva...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000445044

    authors: Chang SH,Lee AY,Yu KN,Park J,Kim KP,Cho MH

    更新日期:2016-01-01 00:00:00

  • Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.

    abstract::The in vitro activities of the newer agents Deptomycin, Difloxacin, A-56620 and Ciprofloxacin were compared with those of vancomycin, rifampin and gentamicin against methicillin-susceptible and -resistant Staphylococcus aureus and coagulase-negative staphylococci. All isolates were susceptible to vancomycin, rifampin,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238691

    authors: Chandrasekar PH,Sluchak JA

    更新日期:1989-01-01 00:00:00

  • Once-daily ceftriaxone in the treatment of lower respiratory tract infections.

    abstract::We conducted a retrospective clinical evaluation to assess the efficacy of a 1-gram once-daily regimen of intravenously administered ceftriaxone in the treatment of a variety of bacterial infections. Of the 250 patients studied, 167 had infections of the lower respiratory tract, approximately 70% of which were diagnos...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238927

    authors: Brown R

    更新日期:1991-01-01 00:00:00

  • Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytes.

    abstract::Among third-generation cephalosporins, cefodizime (CFDZ) has shown to modulate many functions of the host defense system against infections. The aim of the present study was to assess the in vitro CFDZ-dependent modulation of interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha) and IL-8 release from lipopolysac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239358

    authors: Meloni F,Ballabio P,Bianchi L,Grassi FA,Gialdroni Grassi GG

    更新日期:1995-07-01 00:00:00

  • In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.

    abstract:BACKGROUND:Ceftazidime is a third-generation cephalosporin almost entirely eliminated by glomerular filtration and dose reductions are essential in patients with renal impairment. The physicochemical and pharmacokinetic properties of ceftazidime make it susceptible to be eliminated by continuous renal replacement thera...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000100864

    authors: Isla A,Gascón AR,Maynar J,Arzuaga A,Sánchez-Izquierdo JA,Pedraz JL

    更新日期:2007-01-01 00:00:00

  • Nevirapine toxicity in non-HIV cancer patients.

    abstract:BACKGROUND:Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor used in HIV patients and recently evaluated as a differentiating and antiproliferative agent in human malignancies. However, while NVP is a safe treatment in immunocompromised patients, NVP-containing regimens have been associated with sever...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000159273

    authors: Landriscina M,Fabiano A,Lombardi V,Santodirocco M,Piscazzi A,Fersini A,De Vis K,Barone C,Cignarelli M

    更新日期:2008-01-01 00:00:00

  • Pharmacokinetics of ertapenem in colorectal tissue.

    abstract:BACKGROUND:There are only limited data on tissue kinetics of ertapenem in colorectal tissue more than 3 h after administration of the drug. The purpose of this study was to assess the pharmacokinetics (PK) of ertapenem in colorectal tissue via population PK modeling. PATIENTS AND METHODS:Patients ≥18 years requiring s...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000333377

    authors: Wittau M,Scheele J,Bulitta JB,Mayer B,Kaever V,Burhenne H,Henne-Bruns D,Isenmann R,Brockschmidt C

    更新日期:2011-01-01 00:00:00

  • Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole.

    abstract::During the 5-year period 1989-1993, the incidence of Candida krusei, and other non-albicans Candida spp., was analyzed in a 60-bed cancer department. The frequency of C. krusei, before fluconazole was introduced into therapeutic protocols in 1990, was 16.5%, and after introduction of fluconazole into prophylaxis in ac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239322

    authors: Kunová A,Trupl J,Spánik S,Drgona L,Sufliarsky J,Lacka J,Studená V,Hlavácová E,Studená M,Kukucková E

    更新日期:1995-01-01 00:00:00